Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Megakaryocytes Internalize and Are Activated by Immune Complexes.

Circulation research·2026
Same author

Secretome From Human Micro-Fragmented Adipose Tissue Affects In Vitro Monocytes/Macrophages Inflammatory Activity by ICAM-1 Expression.

Mediators of inflammation·2026
Same author

The interface of hemostasis and inflammation: endothelial-platelet dynamics in thrombosis.

Current opinion in hematology·2026
Same author

Platelet dysfunction in chronic kidney disease arises from bone marrow remodeling and megakaryocyte reprogramming.

Blood advances·2025
Same author

Use of a conditional Glanzmann thrombasthenia mouse model reveals a supportive and possibly non-adhesive role for TLT-1 in the platelet-fibrinogen interaction.

Platelets·2025
Same author

Induction of moderate DNA damage enhances megakaryopoiesis and platelet production.

Blood advances·2025

相关实验视频

Updated: Jun 12, 2026

High-throughput Purification of Affinity-tagged Recombinant Proteins
07:44

High-throughput Purification of Affinity-tagged Recombinant Proteins

Published on: August 26, 2012

14.2K

询问一个化合物库,寻找TREM类转录-1到纤维素因子结合的抑制剂

Andrea Acsiniuc1, Barbara Manfredi2, Javier Menédez-Pérez3

  • 1Oakland University, United States.

The Journal of pharmacology and experimental therapeutics
|July 19, 2024
PubMed
概括

研究人员确定了TREM样转录-1 (TLT-1) 的强有力的小分子抑制剂,TREM样转录-1 (TLT-1) 是血液凝块形成中的关键受体. 这一发现为预防心血管疾病 (CVD) 和血栓形成提供了新的治疗策略.

关键词:
血小板是血小板的组成部分.对受体结合的研究.心血管疾病心血管疾病药物的开发/发现.

更多相关视频

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
06:27

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy

Published on: November 30, 2018

9.2K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.1K

相关实验视频

Last Updated: Jun 12, 2026

High-throughput Purification of Affinity-tagged Recombinant Proteins
07:44

High-throughput Purification of Affinity-tagged Recombinant Proteins

Published on: August 26, 2012

14.2K
Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
06:27

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy

Published on: November 30, 2018

9.2K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.1K

科学领域:

  • 生物化学 生物化学
  • 药理学 药理学是指药理学的学科.
  • 心血管研究研究心血管研究

背景情况:

  • 心血管疾病 (CVD) 是全球主要的死亡原因,通常是由异常的血小板功能和血栓形成驱动的.
  • 类似TREM的转录-1 (TLT-1),一个血小板释放的受体,结合纤维素素和·维勒布兰德因子,在血栓形成中发挥关键作用.
  • TLT-1为预防心血管疾病相关的血栓形成提供了潜在的治疗标.

研究的目的:

  • 设计和实施一种高通量试验,用于选TLT-1和纤维素因子结合的小分子抑制剂.
  • 为了确定可以抑制TLT-1的血栓活性的新型化合物.
  • 为了验证已识别的抑制化合物的疗效和安全性.

主要方法:

  • 开发了一种使用HEK-293细胞表达人类TLT-1的附着试验,以选800个小分子以抑制TLT-1/纤维素原结合.
  • 使用晶体紫色染色来评估细胞粘附和抑制.
  • 采用MTT和calcein AM染色试验来评估化合物细胞毒性并确认抑制不是由于细胞死亡.

主要成果:

  • 该试验表明,TLT-1表达增加了细胞粘附率超过2倍.
  • 确定了大约80种化合物,抑制了TLT-1/纤维激素结合的80%以上.
  • 细胞毒性测定证实,观察到的抑制不是化合物毒性的结果. 四种化合物显示出潜在的作用,BM-8372显著影响了血小板聚合.

结论:

  • 为了选TLT-1的抑制剂,这是血栓形成的关键媒介,建立了一个强大的测试.
  • 查发现了TLT-1/纤维素原结合的强大小分子抑制剂,细胞毒性最小.
  • 这些发现为开发新型抗血栓策略以对抗心血管疾病提供了有希望的治疗候选者.